AshitaJTolwaniMDM.Sc.

PubMed

• CKD Progression following Acute Kidney Injury: A Secondary Analysis of the STARRT-AKI Trial.
  Sara Wing, Ary Serpa Neto, Rinaldo Bellomo, Edward G Clark, Martin Gallagher
  Kidney360. 2024-12-03
• 4 citations
  CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel.
  John A Kellum, Sean M Bagshaw, Sevag Demirjian, Lui Forni, Michael Joannidis
  Journal of Critical Care. 2024-08-01
• How Low Can You Go With Dose of Continuous Kidney Replacement Therapy? Is That the Right Question to Ask?
  J Pedro Teixeira, Ashita Tolwani, Javier A Neyra
  American Journal of Kidney Diseases. 2024-08-01

Journal Articles

• Association between renal replacement therapy in critically ill patients with severe acute kidney disease and mortality  
  Bagshaw SM, Uchino S, Kellum JA, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Bellomo R; Beginn..., J Crit Care, 12/1/2013
• KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury  
  Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD, Am J Kidney Dis, 3/14/2013
• Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative?  
  Tolwani A, Wille KM, Am J kid Dis, 6/1/2012
• Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group  
  Nadim MK, Kellum JA, Davenport A, Wong, F, Davis, C, Pannu N, Tolwani A, Bellomo R, Genyk Y, Critical Care, 2/1/2012
• Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 Patients Treated with Concomitant CRRT  
  Bauer SR, Salem C, Connor MJ Jr, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH, Clin J Am SocNephrol, 1/26/2012
• Advances in continuous renal replacement therapy: citrate anticoagulation update  
  Tolwani A, Wille KM, Blood Purification, 1/1/2012
• Critical care nephrology: management of acid-base disorders with CRRT  
  Cerda J, Tolwani AJ, Warnock DG, Kidney Int., 8/3/2011
• Solute clearance in CRRT: prescribed dose versus actual delivered dose  
  Lyndon WD, Wille K, Tolwani AJ, Nephrol. Dial. Transplant., 1/1/2011
• A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure  
  Humes, H.D., Sobota, J.T., Ding, F. & Song, J.H. RAD Investigator Group, Blood Purif, 1/1/2010
• Development, implementation, and results of the ASN in-training examination for fellows  
  Rosner, M.H., Berns, J. S., Parker, M., Tolwani, A., Bailey, J., DiGiovanni, S., Lederer, E., Norby, S., Plumb, T. J., Qian, Q., Yeun, J., Hawley, J. L., Owens, S., Clin J Am SocNephrol, 1/1/2010
• Citrate anticoagulation for continuous renal replacement therapy(CRRT) in patients with acute kidney injury admitted to the intensivecare unit  
  Davenport A, Tolwani A., NDT Plus, 1/1/2009
• Introduction The clinical application of CRRT-current status  
  Tolwani, A.J.& Palevsky, P.M., Semin Dial, 1/1/2009
• Delivery of renal replacement therapy in acute kidney injury: what are the key issues?  
  Davenport, A., Bouman, C., Kirpalani, A., Skippen, P., Tolwani, A., Mehta, R. L., Palevsky, P. M., Clin J Am SocNephrol, 1/1/2008
• Efficacy and safety of renal tubule cell therapy for acute renal failure  
  Tumlin, J., Wali, R., Williams, W., Murray, P., Tolwani, A. J., Vinnikova, A. K., Szerlip, H. M., Ye, J., Paganini, E. P., Dworkin, L., Finkel, K. W., Kraus, M. A., Hu..., J Am SocNephrol, 1/1/2008
• Standard versus high-dose CVVHDF for ICU-related acute renal failure  
  Tolwani, A.J., Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM, J Am SocNephrol, 1/1/2008
• The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts  
  Pisoni, R., Wille, K.M. &Tolwani, A.J., Nephron ClinPract, 1/1/2008
• Sustained low-efficiency dialysis  
  Tolwani, A.J., Wheeler, T.S. & Wille, K.M., ContribNephrol, 1/1/2007
• Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes  
  Bagshaw, S.M., Uchino, S., Bellomo, R., Morimatsu, H., Morgera, S., Schetz, M., Tan, I., Bouman, C., Macedo, E., Gibney, N., Tolwani, A., Oudemans-van Straaten, H. M.,..., Clin J Am SocNephrol, 1/1/2007
• Citrate-based replacement solution with continuous venovenous hemofiltration: not as simple as it sounds  
  Tolwani A, Wille KM, Am J Kid Dis, 6/1/2006
• A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance  
  Tolwani, A.J., Prendergast, M.B., Speer, R.R., Stofan, B.S. & Wille, K.M., Clin J Am SocNephrol, 1/1/2006
• Vascular grafts for hemodialysis: types, sites and techniques  
  Warnock, D.G., Tolwani, A.J., Gallichio, M. & Allon, M., ContribNephrol, 1/1/2004
• Normal radiographs in patients with persistent "hip pain"-value of magnetic resonance imaging  
  Lopez-Ben, R., Tolwani, A., Chatham, W., Pitt, M.J. & Alarcon, G.S., J Rheumatol, 1/1/2002
• Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimirisciureus)  
  Tolwani RJ, Waggie KS, Green SL, Tolwani AJ, Lyons DM, Schatzberg AF, J Med Primatol, 1/1/2000
• Join now to see all

Books/Book Chapters

• Perioperative Kidney Injury:Principles of Risk Assessment, Diagnosis and Treatment 
  Chapter: Clinical Pearls: Renal Replacement Therapy for Acute Kidney Injury in the Postoperative Period. 
  Ashita J. Tolwani and Paul M. PalevskyEditors: Thakar, Charuhas V., Parikh, Chirag R..2015
• Specific Gene Expression and Epigenetics: The Interplay Between the Genome and Its Environment 
  Chapter: Eukaryotic DNA Methylation:Renal Kallikrein Excretion and Epigenetics in Human Acute Kidney Injury: Expression, Mechanisms and Consequences. 
  Sun Woo Kang, Pei-an Betty Shih, Roy O. Mathew, Manjula Mahata, Nilima Biswas, Fangwen Rao, Liying Yan, Josee Bouchard, Rakesh Malhotra, Ashita Tolwani, Srikrishna Kha...Editors: Kasirajan Ayyanathan.Apple Academic PressEdition 1st,2014
• Clinical Decision Support System on Nephrology and Hypertension (Digital Educational Support System) 
  Chapter: Acute Kidney Injury: Role of Acute Dialysis (CRRT, SLED, intermittent hemodialysis, other) 
  Rolando Claure, Ashita J Tolwani, Ravindra Mehta2013
• Modeling and Control of Dialysis Systems: Volume 2: Biofeedback Systems and Soft Computing Techniques of Dialysis 
  Chapter: Continuous Renal Replacement Therapy. 
  Jorge Cerda, Ashita Tolwani, Shamik Shah, Claudio RoncoEditors: Ahmad Azar.2013
• Clinical Decisions in Nephrology, Hypertension, and Kidney Transplantation 
  Chapter: "Part V Acute Kidney Injury" 
  Tolwani A (Section Editor)Editors: Edgar Lerma, MD and Mitchell Rosner, MD.2013
• Clinical Decisions in Nephrology, Hypertension, and Kidney Transplantation 
  Chapter: Acute kidney Injury: Definitions and General Approach 
  Ashita J TolwaniEditors: Edgar Lerma, MD and Mitchell Rosner, MD.2013
• Clinical Decisions in Nephrology, Hypertension, and Kidney Transplantation 
  Chapter: Specific Etiologies 
  Eric K Judd, Shikha Mehta, Ashita J TolwaniEditors: Edgar Lerma, MD and Mitchell Rosner, MD.2013
• Annual Update in Intensive Care and Emergency Medicine 
  Chapter: Does The Choice of Renal Replacement Therapy Affect Renal Recovery? 
  Nakshatra Saxena, Ashita J. Tolwani, Keith M. WilleEditors: Jean-Louis Vincent.2013
• UpToDate 
  Chapter: Anticoagulation for continuous renal replacement therpay. 
  Ashita J Tolwani, Keith M. WilleEditors: Schwab, SJ.UpToDate, Waltham, MA2013
• Encyclopedia of Intensive Care Medicine 
  Chapter: Citrate Anticoagulation for CRRT. 
  Tolwani AEditors: Vincent, Jean-Louis; Hall, Jesse B.Edition 1st,2012
• Comprehensive Critical Care: Adult. Society of Critical Care Medicine 
  Chapter: Acute and Chronic Renal Failure and Management. 
  Michael L. Bentley, PharmD, FCCM, and Ashita J. Tolwani, MD, MScEditors: Pamela R. Roberts, MD, FCCM, Editor; S. Rob Todd, MD, FACS.2012
• Critical Care Nephrology 
  Chapter: Extracorporeal Liver Support and the Kidney 
  Tolwani A and Wille KEditors: Ronco C and Bellomo R.Saunders Elsevier, Philadelphia, PAEdition 2nd,2009
• Epidemiology and Biostatistics Secrets 
  Chapter: Research Model Designs 
  Ashita Tolwani, MD, MScEditors: Robert Nordness, MD, MPH.Elsevier, Inc.2006
• Epidemiology and Biostatistics Secrets 
  Chapter: Survival Analysis 
  Ashita Tolwani, MD, MScEditors: Robert Nordness, MD, MPH.Elsevier, Inc.2006
• Join now to see all

Abstracts/Posters

• Serum Kidney Injury Molecule-1 Levels in Acute Kidney Injury.
  Josee Bouchard, Rakesh Malhotra, Ashita J. Tolwani, Ravindra L. Mehta, ASN, Philadelphia, PA, 11/1/2014
• Continuous Venovenous Hemodiafiltration to Obtain Therapeutic Hypernatremia in Patients with Renal Failure: A Case Series.
  Timothy A. Williams, Keith M. Wille, Ashita J. Tolwani, ASN, Philadelphia, PA, 11/1/2014
• Clinical Outcomes of Patients with Respiratory Failure from Influenza on Combined ECMO and CRRT.
  Vinayak Ramanath, MD, Keith Wille, MD, Enrique Diaz-Guzman MD, Ashita Tolwani, MD, National Kidney Foundation Clinical Meeting, Las Vegas, NV, 4/1/2014
• Using Simple Solutions in Tough Situations: Citrate Anticoagulation Protocol Using Calcium Containing Replacement Fluid.
  Nithin Karakala, Tracie Delay, Ruth C Campbell, John Arthur, Ashita Tolwani, ASN, Atlanta, GA, 11/1/2013
• A Continuous Veno-Venous Hemofiltration Protocol with Anticoagulant Citrate Dextrose Formula A and a Calcium-Containing Replacement Fluid: An Easy Remedy for the Natio...
  Song Ching Ong, Keith M. Wille, Ashita J. Tolwani, ASN, Atlanta, GA, 11/1/2013
• Innovations in CRRT Training: Leveraging simulation for a multidisciplinary CRRT Symposium.
  A.Tolwani, D. James, M. Andison, R. Speer, K. Eggelston, CRRT conference, San Diego, CA, 2/1/2013
• Epidemiology of Acute Kidney Injury from the O'Brien Center Registry.
  Josee Bouchard, MD, Anjali Acharya, MD, FASN, Jorge Cerda, MD, FASN, Elizabeth R. Maccariello, MD, PhD, Rajasekara Chakravarthi Madarasu, MD, PhD, Ashita J. Tolwani, M..., ASN, San Diego, CA, 11/1/2012
• Mode and dose of continuous renal replacement therapy (CRRT) affect estimation of plasma piperacillin levels from CRRT effluent.
  Ashita J. Tolwani, Peilin Wei, M.D., Maria E. Taylor, PharmD, Seth R. Bauer PharmD, Charbel A Salem, M.D. Milen Amde M.D., Michael J. Connor M.D., William H. Fissell M.D., CRRT conference, San Diego, CA, 2/1/2012
• Post filter ionized calcium levels with dilute regional citrate anticoagulation: do we need to follow them?
  Rajesh Speer, Pharm. D., Dmitri Sychev, M.D., Ashita Tolwani, M.D., CRRT conference, San Diego, CA, 2/1/2012
• Factors Associated with the Decision Making Process in Dialysis Initiation inAKI: Results of a Survey.
  Etienne Macedo, MD, Josee Bouchard, MD, Jorge Cerda, MD,FASN, Ashita J. Tolwani, MD, Anjali Acharya, MD, Gary R. Cutter, PhD, RavindraL. Mehta, MD, FASN, ASN, Philadelphia, PA, 11/1/2011
• A Comparison of Clinical Outcomes between the Selective CytophereticDevice and Case-Matched Historical Controls from the PICARD Database.
  Ravindra L. Mehta, MD, FASN, Alexander S. Yevzlin, MD, James A. Tumlin, MD, Lakhmir S. Chawla, MD, Ashita J. Tolwani, MD, John J. Dillon,MD, Kevin W. Finkel, MD, FASN,..., ASN, Philadelphia, PA, 11/1/2011
• Predictive Performance of Biomarkers in Acute Kidney Injury (AKI) Using AKI Network (AKIN) Serum Creatinine or Urine Output Criteria.
  Josee Bouchard, MD, Rakesh Malhotra, MD, Ashita J. Tolwani,MD, Ravindra L. Mehta, MD, FASN, ASN, Philadelphia, PA, 11/1/2011
• Can Objective Criteria Improve Decisions for Dialysis Initiation in AKI?
  Etienne Macedo, MD, Josee Bouchard, MD, Jorge Cerda, MD, FASN, Ashita J. Tolwani, MD, Anjali Acharya, MD, Gary R. Cutter, PhD, RavindraL. Mehta, MD, FASN, ASN, Philadelphia, PA, 11/1/2011
• Clinical Data Imperfectly Predict Piperacillin Pharmacokinetics in Patients onContinuous Renal Replacement Therapy.
  Peilin Wei, MD, Seth R. Bauer, PharmD, Charbel A. Salem, MD,Joseph J. Groszek, Maria E. Taylor, PhD, Michael J. Connor, MD, Ashita J. Tolwani,MD, William Fissell, MD, ASN, Philadelphia, PA, 11/1/2011
• Piperacillin Clearance in Continuous Renal Replacement Therapy (CRRT) Predicts Failure To Reach Pharmacodynamic Targets.
  Seth R. Bauer, PharmD, Peilin Wei, MD, Charbel A. Salem, MD, Joseph J. Groszek, Maria E. Taylor, PhD, Michael J. Connor, MD, Ashita J. Tolwani,MD, William Fissell, MD, ASN, Philadelphia, PA, 11/1/2011
• Piperacillin Pharmacodynamics Are Associated with Survival in Continuous Renal Replacement Therapy (CRRT).
  Charbel A. Salem, MD, Peilin Wei, MD, Maria E. Taylor, PhD, Seth R. Bauer, PharmD, Michael J. Connor, MD, Joseph J. Groszek, Ashita J. Tolwani, MD, William Fissell, MD, ASN, Philadelphia, PA, 11/1/2011
• A Multi-Center Pilot Study to Assess the Safety and Efficacy of Selective Cytopheretic Device (SCD) Therapy in Patients with Acute Kidney Injury (AKI).
  James A. Tumlin, MD, Lakhmir S. Chawla, MD, Ashita J.Tolwani, MD, John J. Dillon, MD, Ravindra L. Mehta, MD, FASN, Kevin W. Finkel,MD, FASN, J. Ricardo Da silva, Alexa..., ASN, Philadelphia, PA, 11/1/2011
• Biomarkers in Acute Kidney Injury: Should We Assess Them in Serum or Urine?
  Josee Bouchard, MD, Rakesh Malhotra, MD, Ashita J. Tolwani, MD, Ravindra L. Mehta, MD, FASN, ASN, Philadelphia, PA, 11/1/2011
• Natural History of Acute Kidney Injury in Intensive Care Unit Patients: The Multicenter International O'Brien Center Registry.
  Josee Bouchard, MD, Jiandong Wei, MD, Sharon Soroko, Anjali Acharya, MD, Jorge Cerda, MD, FASN, Elizabeth R. Maccariello, MD, PhD, Rajasekara Chakravarthi Madarasu, MD..., ASN, Philadelphia, PA, 11/1/2011
• Solute Clearance in CRRT: Comparing Measured Effluent Volume to Actual Delivered Dose.
  W. Lyndon, K. Wille, A. Tolwani, NKF, Las Vegas, NV, 4/1/2011
• Solute Clearance in CRRT: Comparing Measured Effluent Volume to Actual Delivered Dose.
  W. Lyndon, K. Wille, A. Tolwani, CRRT Conference, San Diego, CA, 2/22/2011
• Soluble Thrombomodulin Levels in Acute Kidney Injury.
  J Bouchard, R Malhotra, S Soroko, A Gupta, D Berg, A Tolwani, R Mehta, ASN, Denver, CO, 11/1/2010
• Postfilter Normal Saline Infusion to Prevent Circuit Clotting with Prismaflex Continuous Renal Replacement Therapy.
  W. Peterson, M. Andison, K. Wille, R. Speer, and A. Tolwani, CRRT Conference, San Diego, CA, 2/2/2010
• Protein C: a potential biomarker for acute kidney injury?
  J Bouchard, R Malhotra, S, Shah, S Soroko, N Khosla, B Stofan, A Tolwani, and RL Mehta, ASN Conference, San Diego, CA, 10/1/2009
• Effect of Timing of Initiation of CRRT on Renal Recovery.
  Roman Shingarev, Ashita Tolwani, Southern Society for Clinical Investigation, New Orleans, 2/1/2009
• Join now to see all

Lectures

• "Adapting to Adversity: Drug Shortages in CRRT" 
  San Diego, CA - 1/1/2015
• Chair/Moderator: "AKI: Interventions, Biomarkers, Genetics, and More Abstract Session" 
  Philadelphia, PA - 11/13/2014
• "Renal Pathophysiology of AKI" 
  10/14/2014
• Renal Grand Rounds: "CRRT in Critical Care" 
  Winthrop-University Hospital, Mineola, NY - 10/10/2014
• "CRRT and Citrate" 
  9/30/2014
• "Acid-Base" 
  8/8/2014
• "Fundamentals of Continuous Renal Replacement Therapies (CRRT), Part II" 
  7/24/2014
• "Intravenous Fluids: A Clinical Approach" 
  4/15/2014
• "AKI and nephrotoxins" 
  3/25/2014
• Co-Chair: "Fundamentals of CRRT" 
  San Diego, CA, 2010, 2011, 2012, 2013 - 3/4/2014
• "Fundamentals of CRRT: "Case Discussions" 
  San Diego, CA, 2011, 2013 - 3/4/2014
• "When to initiate RRT" 
  2/24/2014
• "CRRT Fundamentals" 
  1/28/2014
• "Acute Kidney Injury Update" 
  1/8/2014
• "Catheters in the AKI Setting: Where to Place and How to Lock" 
  Atlanta, GA - 11/7/2013
• Chair/Moderator: "AKI oral abstract session" 
  Atlanta, GA - 11/7/2013
• "Acute Renal Replacement Therapy and Acute Kidney Injury Cases" 
  San Francisco, CA - 8/29/2013
• "Advanced CRRT: Solute Clearance" 
  8/8/2013
• "Fundamentals of Continuous Renal Replacement Therapies (CRRT), Part I" 
  8/1/2013
• "Defining fluid overload and its' effect on outcomes" 
  New Orleans, LA - 6/15/2013
• "The use of RIFLE in accessing renal function" 
  New Orleans, LA - 6/15/2013
• "Anticoagulation Strategies for Continuous Renal Replacement Therapy" 
  Shanghai, China - 6/6/2013
• "Continuous Renal Replacement Therapy for Acute Kidney Injury" 
  Shanghai, China - 6/6/2013
• "CRRT for Rhabdomyolysis" 
  Chengdu,China - 6/5/2013
• "AKI, CRRT Lectures" 
  5/29/2013
• Join now to see all

Other

• Patient Case Studies. Acute Kidney Injury: Recognition & Risk Assessment in Critically Ill Patients. (A Self-study accredited monography). 
  Bellomo R, Tolwani A, Reilly I, Educational Review Systems (ERS), Medavera, Inc.
  8/1/2013
• The Kidney: Anticoagulation in Continuous Renal Replacement Therapy. 
  Saxena N, Tolwani A, Wille, K, ICU Management: The Official Management and Practice Journal
  1/1/2013
• Approach to the Patient with Asymptomatic Microscopic Hematuria. 
  Tolwani, A, UAB Synopsis (weekly e-newsletter for the UAB Medicine community)
  2/6/2012
• Continuous Renal Replacement Therapy: Modality of Choice in the Intensive Care Unit? 
  Tolwani, A, ASN Kidney News, Volume 2, No. 2
  2/1/2010
• Heparin Lock for Dialysis Catheters. 
  Tolwani, A,Speer, R, UAB Synopsis, Vol 25; No. 28 (A UAB Health System Publication)
  11/6/2006
• Anticoagulation for continuous renal replacement therapy 
  Tolwani AJ, Wille KM
  http://www.uptodate.com/contents/anticoagulation-for-continuous-renal-replacement-therapy
  UpToDate, Wolters Kluwer Health - 2013-04-12
• Join now to see all